Mesotheliomas

This surgery is used to treat pleural mesothelioma, which affects the membrane lining the inner wall of the chest wall and lungs (parietal and visceral pleura).

During pleurectomy, the surgeon removes all of the pleura and surrounding tissue affected by the cancer.

This surgery aims to remove the tumor without removing the underlying lung in order to relieve associated symptoms, such as chest pain and fluid accumulation in the chest (pleural effusion).

Pleurectomy can sometimes be enlarged by removing neighboring organs involved in the disease.

Pleurectomy may be expanded to the diaphragmatic muscle in some cases because mesothelioma can spread and infiltrate this anatomical structure that separates the thoracic and abdominal cavities. Surgical excision involves excision of part or all of the diaphragm and its reconstruction with or without prosthetic replacement.

If mesothelioma spreads to the pericardium (the membrane that surrounds the heart), surgical removal of the affected pericardium and its replacement by synthetic or biological prostheses may be necessary.

In very advanced cases of pleural mesothelioma in which the tumor significantly involves one lung, it may be necessary to remove the entire affected lung surgically.

This procedure can be performed in conjunction with pleurectomy. After surgical removal of the tumor, a chemotherapy solution heated to 41°/42° for about 60 minutes is circulated directly into the chest cavity to produce the death of any remaining cancer cells. Surgical treatment of mesothelioma is usually part of a multimodal approach, that is, combined with other forms of therapy, such as chemotherapy and radiation therapy, to improve the overall effectiveness of treatment and to manage the disease more comprehensively. The choice of treatment depends on several factors, including the stage of the tumor, the patient’s overall health, and personal preference. Surgical treatment of mesothelioma depends on the staging of the disease and its extent.

This surgery is used to treat pleural mesothelioma, which affects the membrane lining the inner wall of the chest wall and lungs (parietal and visceral pleura).

During pleurectomy, the surgeon removes all of the pleura and surrounding tissue affected by the cancer.

This surgery aims to remove the tumor without removing the underlying lung in order to relieve associated symptoms, such as chest pain and fluid accumulation in the chest (pleural effusion).

Pleurectomy can sometimes be enlarged by removing neighboring organs involved in the disease.

Pleurectomy may be expanded to the diaphragmatic muscle in some cases because mesothelioma can spread and infiltrate this anatomical structure that separates the thoracic and abdominal cavities. Surgical excision involves excision of part or all of the diaphragm and its reconstruction with or without prosthetic replacement.

If mesothelioma spreads to the pericardium (the membrane that surrounds the heart), surgical removal of the affected pericardium and its replacement by synthetic or biological prostheses may be necessary.

In very advanced cases of pleural mesothelioma in which the tumor significantly involves one lung, it may be necessary to remove the entire affected lung surgically.

This procedure can be performed in conjunction with pleurectomy. After surgical removal of the tumor, a chemotherapy solution heated to 41°/42° for about 60 minutes is circulated directly into the chest cavity to produce the death of any remaining cancer cells. Surgical treatment of mesothelioma is usually part of a multimodal approach, that is, combined with other forms of therapy, such as chemotherapy and radiation therapy, to improve the overall effectiveness of treatment and to manage the disease more comprehensively. The choice of treatment depends on several factors, including the stage of the tumor, the patient’s overall health, and personal preference. Surgical treatment of mesothelioma depends on the staging of the disease and its extent.

This surgery is used to treat pleural mesothelioma, which affects the membrane lining the inner wall of the chest wall and lungs (parietal and visceral pleura).

During pleurectomy, the surgeon removes all of the pleura and surrounding tissue affected by the cancer.

This surgery aims to remove the tumor without removing the underlying lung in order to relieve associated symptoms, such as chest pain and fluid accumulation in the chest (pleural effusion).

Pleurectomy can sometimes be enlarged by removing neighboring organs involved in the disease.

Pleurectomy may be expanded to the diaphragmatic muscle in some cases because mesothelioma can spread and infiltrate this anatomical structure that separates the thoracic and abdominal cavities. Surgical excision involves excision of part or all of the diaphragm and its reconstruction with or without prosthetic replacement.

If mesothelioma spreads to the pericardium (the membrane that surrounds the heart), surgical removal of the affected pericardium and its replacement by synthetic or biological prostheses may be necessary.

In very advanced cases of pleural mesothelioma in which the tumor significantly involves one lung, it may be necessary to remove the entire affected lung surgically.

This procedure can be performed in conjunction with pleurectomy. After surgical removal of the tumor, a chemotherapy solution heated to 41°/42° for about 60 minutes is circulated directly into the chest cavity to produce the death of any remaining cancer cells. Surgical treatment of mesothelioma is usually part of a multimodal approach, that is, combined with other forms of therapy, such as chemotherapy and radiation therapy, to improve the overall effectiveness of treatment and to manage the disease more comprehensively. The choice of treatment depends on several factors, including the stage of the tumor, the patient’s overall health, and personal preference. Surgical treatment of mesothelioma depends on the staging of the disease and its extent.

This surgery is used to treat pleural mesothelioma, which affects the membrane lining the inner wall of the chest wall and lungs (parietal and visceral pleura).

During pleurectomy, the surgeon removes all of the pleura and surrounding tissue affected by the cancer.

This surgery aims to remove the tumor without removing the underlying lung in order to relieve associated symptoms, such as chest pain and fluid accumulation in the chest (pleural effusion).

Pleurectomy can sometimes be enlarged by removing neighboring organs involved in the disease.

Pleurectomy may be expanded to the diaphragmatic muscle in some cases because mesothelioma can spread and infiltrate this anatomical structure that separates the thoracic and abdominal cavities. Surgical excision involves excision of part or all of the diaphragm and its reconstruction with or without prosthetic replacement.

If mesothelioma spreads to the pericardium (the membrane that surrounds the heart), surgical removal of the affected pericardium and its replacement by synthetic or biological prostheses may be necessary.

In very advanced cases of pleural mesothelioma in which the tumor significantly involves one lung, it may be necessary to remove the entire affected lung surgically.

This procedure can be performed in conjunction with pleurectomy. After surgical removal of the tumor, a chemotherapy solution heated to 41°/42° for about 60 minutes is circulated directly into the chest cavity to produce the death of any remaining cancer cells. Surgical treatment of mesothelioma is usually part of a multimodal approach, that is, combined with other forms of therapy, such as chemotherapy and radiation therapy, to improve the overall effectiveness of treatment and to manage the disease more comprehensively. The choice of treatment depends on several factors, including the stage of the tumor, the patient’s overall health, and personal preference. Surgical treatment of mesothelioma depends on the staging of the disease and its extent.

Due to the high number of cases treated each year, the Candiolo Institute is a national reference for taking care of esophageal cancer. Our experience enables us to deal with even the most complex situations, always with a personalized approach built on the clinical and personal profile of each patient.

Establishing the treatment plan always starts with an accurate and timely diagnosis. Patients have access to state-of-the-art imaging technologies that allow accurate assessment of the extent of the disease.

In addition, the Institute offers advanced and sophisticated laboratory investigations, including molecular and genomic analyses, which are critical for identifying biological features of cancer and guiding therapeutic decisions.

When indicated, surgery is performed with minimally invasive techniques (laparoscopic or thoracoscopic), which reduce operative trauma, promote faster recovery, and improve postoperative quality of life. Every treatment choice is defined within the GIC, ensuring a consistent and integrated approach.

As an IRCCS, the Candiolo Institute combines clinical practice with a strong vocation for scientific research. Patients can be evaluated for inclusion in active clinical trials, which represent a real chance to access innovative therapies not yet available in standard practice. Collaboration between care and research is a distinctive value that translates into concrete opportunities for the patient.

The Interdisciplinary Care Group takes care of the person at every stage: from diagnosis to treatment to follow-up, with attention to nutritional support, psychological health, and reintegration into daily life. The organization of checkups, visits and treatment is designed to ensure continuity and serenity, always valuing the human dimension of care.